The company is in deep distress — common equity is likely worthless in a Chapter 11 given $78M+ in unsecured debt and a negative equity trajectory. Monitor for a plan of reorganization, asset sales, or potential conversion to Chapter 7. Trading in SGMOQ is highly speculative and priced on recovery assumptions for unsecured creditors, not equity value.
Price Chart
Executive Summary
Sangamo Therapeutics, Inc. filed its first monthly operating report (MOR) with the Bankruptcy Court for the period June 23–30, 2026, following its Chapter 11 filing on June 23, 2026. The report shows minimal revenue of $108,953, a net loss of $3,755,058, and a cash burn that was offset by a $10,500,000 DIP draw, leaving $14.4M in cash at month-end. The company has $78.1M in prepetition unsecured debt against $153.1M in total assets, with stockholder equity declining from $26.3M to $22.6M in just one week.
Key Facts
- Chapter 11 petition filed June 23, 2026; Nasdaq delisting finalized May 2026
- Revenue for 8-day post-petition period: $108,953
- Net loss for the period: $3,755,058
- Cash balance end of period: $14,382,243 (started at $4,857,102)
- Total receipts: $10,503,072 (DIP draw of $10,500,000 + $3,072 operational)
- Prepetition unsecured debt: $78,129,568
- Total liabilities: $89,151,054
- Total assets: $153,087,245; Stockholders' equity: $22,642,000 (down from $26,342,000 at petition)
- Current employees: 73 (down from 74 at petition date)
- Postpetition payables: $10,929,227
- No plan of reorganization or disclosure statement filed yet with the court
- Common stock trading on OTCQB under SGMOQ; Nasdaq previously suspended trading May 5, 2026
Financial Impact
Chapter 11 filing with $78.1M in unsecured debt, $3.8M net loss in first week, minimal revenue of $109K
Risk Factors
- Equity likely to be extinguished or massively diluted in Chapter 11 restructuring
- No plan of reorganization filed — uncertainty on recovery for any stakeholder class
- Cash burn rate ~$3.8M per week before DIP, suggesting limited liquidity runway
- OTC trading has low liquidity and no Nasdaq delisting appeal remaining
- Postpetition liabilities of ~$11M will pressure any restructuring efforts
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-346796 |
| Document: d21956d8k.htm | 0001193125-26-346796 |
| Document: 0001193125-26-346796-index-headers.html | 0001193125-26-346796 |
| Document: 0001193125-26-346796-index.html | 0001193125-26-346796 |
| Document: 0001193125-26-346796.txt | 0001193125-26-346796 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 8-K | $0.1100 $0.1200 | ▼ −9.09% | ▼ −9.52% | $0.1200 (−9.09%) |
Oct 6, 2026 20d ago | 25-NSE | $0.1400 $0.1400 | · 0.00% | ▼ −0.98% | $0.1200 (+14.29%) |
Aug 28, 2026 8w ago | 8-K | $0.1600 $0.1600 | · 0.00% | ▼ −0.14% | $0.1200 (+25.00%) |
Aug 12, 2026 10w ago | 8-K | $0.1700 $0.1602 | ▼ −5.76% | ▼ −3.80% | $0.1200 (−29.41%) |
Aug 12, 2026 10w ago | 8-K | $0.1700 $0.1602 | ▲ +5.76% | ▲ +3.80% | $0.1200 (+29.41%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers